New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. [electronic resource]
- Journal of the National Comprehensive Cancer Network : JNCCN 05 2018
- 646-650 p. digital
Publication Type: Journal Article; Practice Guideline
1540-1413
10.6004/jnccn.2018.0042 doi
Antineoplastic Agents--pharmacology Biomarkers, Tumor--antagonists & inhibitors Brachytherapy--methods Costimulatory and Inhibitory T-Cell Receptors--antagonists & inhibitors Disease Progression Disease-Free Survival Eye Enucleation--methods Liver Neoplasms--genetics Lymphatic Metastasis--pathology Medical Oncology--standards Melanoma--genetics Neoadjuvant Therapy--methods Neoplasm Recurrence, Local--genetics Neoplasm Staging Protein Kinase Inhibitors--pharmacology Proto-Oncogene Proteins B-raf--antagonists & inhibitors Randomized Controlled Trials as Topic Skin Neoplasms--genetics Societies, Medical--standards United States Uveal Neoplasms--genetics Uveal Melanoma